ANGIOTECH PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - March 16, 2011

Attached files

file filename
10-K - FORM 10-K - ANGIOTECH PHARMACEUTICALS INCd10k.htm
EX-21 - LIST OF WORLDWIDE SUBSIDIARIES - ANGIOTECH PHARMACEUTICALS INCdex21.htm
EX-12 - STATEMENT RE COMPUTATION OF RATIOS - ANGIOTECH PHARMACEUTICALS INCdex12.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex311.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 906 - ANGIOTECH PHARMACEUTICALS INCdex321.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ANGIOTECH PHARMACEUTICALS INCdex322.htm
EX-10.30 - EXECUTIVE EMPLOYMENT AGREEMENT - STEVE BRYANT - ANGIOTECH PHARMACEUTICALS INCdex1030.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3/A (No. 333-160759) and in the Registration Statement on Form S-8 (No. 333-159222) of Angiotech Pharmaceuticals, Inc. of our report dated March 16, 2011 relating to the consolidated financial statements, the financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

PricewaterhouseCoopers LLP

Vancouver, British Columbia

March 16, 2011

ANGIOTECH PHARMACEUTICALS INC Reports